Reclaimed at end of life
Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.
| Category | FY 2022-23 |
|---|---|
| Plastics including packaging | not filed |
| E-waste | not filed |
| Hazardous waste | not filed |
| Other waste | not filed |
| Total reclaimed | 0 |
Recycled or reused input material
Share of total material by value, per material line as the company named it. Each line carries its own denominator, so they are never summed or averaged.
| Input material, as filed | FY 2022-23 |
|---|---|
| As a pharmaceutical product manufacturer, we are unable to utilize reused or recycled input materials in our production process. Due to the essential nature of the products, their significance in terms of patient health, safety, adherence to pertinent regulations, and involvement in clinical trials, there exists no possibility of reusing or recycling any input material directly linked to these products. | 0.0% |
NIC codes filed
Products and services accounting for 90 percent of turnover, latest filing.
| Code | Description as filed | Share of turnover |
|---|---|---|
| 242 | Manufacturing and Sales of Pharmaceuticals | 100.00% |
Source filings
| Year | Basis | Taxonomy | Turnover as filed |
|---|---|---|---|
| FY 2022-23 | Standalone | 2023-06-30 | 6,73,29,20,000 |
Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error